2. Academic Validation
  3. Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?

Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?

  • Eur Respir J. 2025 Apr 24;65(4):2500153. doi: 10.1183/13993003.00153-2025.
Mohamed-Ilias Kourid 1,  Simon Couillard 2
Affiliations

Affiliations

  • 1 Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
  • 2 Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada [email protected].
PMID: 40274300 DOI: 10.1183/13993003.00153-2025
Figures
Products